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Accepted 17 February 2012A 27-year-old, primigravid woman was referred to hospital
for detailed ultrasound evaluation of the fetus because of first-
trimester increased nuchal translucency (NT). Her husband
was 56 years old. She and her husband were non-
consanguineous, and there were no family history of
congenital malformations. She had a body weight of 40 kg and
a body height of 154 cm and was shorter than her female
relatives. Prenatal ultrasound at 13 weeks of gestation revealed
an increased NT thickness of 3.8 mm (Fig. 1). Level II ultra-
sound examination at 15 weeks of gestation revealed nuchal
edema; a normal amount of amniotic fluid; short limbs; frac-
ture deformities with angulations of the radius, ulna and tibia;
decreased bone density of the cranium; and supervisualization
of the intracranial contents suggesting a lethal form of
osteogenesis imperfecta (OI) type II (Fig. 2). The measure-
ments of the femur, tibia, fibula, humerus, ulna and radius
were 0.97, 0.93, 0.86, 1.51, 1.10 and 1.12 cm, respectively,
and all were less than the fifth centile for 15 weeks. The
woman underwent amniocentesis at 15 weeks of gestation.
Cytogenetic analysis revealed a karyotype of 46,XX. The
pregnancy was terminated. Molecular analyses of the COL1A1
and COL1A2 genes using denaturing high-performance liquid* Corresponding author. Department of Obstetrics and Gynecology, Mackay
Memorial Hospital, 92, Section 2, Chung-Shan North Road, Taipei, Taiwan.
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doi:10.1016/j.tjog.2012.04.032chromatography in the fetus revealed a heterozygous mutation
in intron 25 of the COL1A2 gene, or IVS 25þ11, C>T or
c.1503þ11 C>T (Fig. 3). The father did not have such
a mutation. However, the mother was mosaic for the mutation
(Fig. 3). Postnatal skeletal X-ray confirmed the diagnosis of OI
type II (Fig. 4). Two years later, the mother delivered a healthy
female baby with a body weight of 3200 g without any skeletal
dysplasia.Fig. 1. Prenatal ultrasound at 13 weeks of gestation shows an increased nuchal
translucency thickness of 3.8 mm.
cs & Gynecology. Published by Elsevier Taiwan LLC. All rights reserved.
Fig. 2. Prenatal ultrasound at 15 weeks of gestation shows (A) angulation and fracture of the low limbs, (B) fractures of the left forearm, (C) hypoechogenicity of
the cranium with supervisualization of intracranial contents and (D) nuchal edema.
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characterized by bone hypomineralization and fragility,
prenatal fractures, severe bowing of the long bones and peri-
natal death due to respiratory insufficiency. OI type II is
inherited in an autosomal dominant pattern and can be caused
by heterozygous mutation in the genes of COL1A1 (OMIM
120150) or COL1A2 (OMIM 120160) [1e3]. The present case
had a heterozygous mutation in the COL1A2 gene, andFig. 3. Molecular analysis shows a c.1503þ11 C>T mutation in intron 25 or
IVS 25þ11 C>T in the COL1A2 gene in the fetus. The father is normal, but
the mother is mosaic for the mutation.prenatal ultrasound manifested hypoechogenicity of the
cranium, supervisualization of intracranial contents, and
fractures and severe bowing of the long bones.
The present casewas associatedwith increasedNT in the first
trimester. Skeletal dysplasias have been associated with
increased NT [4e8]. Reported skeletal dysplasias associated
with increased NT include achondrogenesis, OI type II, hypo-
phosphatasia, thanatophoric dysplasia, short rib-polydactyly
syndrome, diastrophic dysplasia, Robinow syndrome, achon-
droplasia, Jarcho-Levin syndrome, cleidocranial dysplasia,
campomelic dysplasia, Jeune syndrome and ectrodactyly-
ectodermal dysplasia-clefting syndrome [7]. It has been sug-
gested that a narrow thorax with mediastinal compression,
reduced movements and alteration of the extracellular matrix
due to collagen defects may be responsible for the genesis of
increased NT [6,7]. To date, at least eight cases of OI type II
associated with increased NT have been reported. Makrydimas
et al [9] reported two cases of OI type II with theNT thickness of
3.4 mm and 4.4 mm at 13 and 11 weeks, respectively. Buisson
et al [10] reported a case of OI type II with increased NT at 13
weeks. Viora et al [11] reported a case of OI type II with NT
thickness of 3.8 mm at 13 weeks. Viora et al [12] reported a case
of OI type II with NT thickness of 3.7 mm at 13 weeks. Cho et al
[13] reported a case of OI type II with generalized edema and
increased NTat 13 weeks. Aerts et al [14] reported a case of OI
type II withNT thickness of 4.5 mmat 16weeks. Hsieh et al [15]
reported a case of OI type II with NT thickness of 4.2 mm at 12
weeks. Scho¨newolf-Greulich et al [16] reported a case ofOI type
II with NT thickness of 3.2 mm at 13 weeks. Our case addi-
tionally adds to the list of cases of OI type II associated with
increased NT in early pregnancy.
Fig. 4. (A) The fetus at birth and (B) the corresponding roentgenograph.
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only phenotypic manifestation was that she was shorter than her
female relatives. Pyott et al [17] found that the rate of parentalmosaicism inwhich a dominantmutationwas identified in a first
affected child was 16%. Recurrence of lethal OI due to parental
mosaicism for a dominant mutation in COL1A1 or COL1A2 has
been reported [17e19]. Recurrence of lethal OI due to parental
mutation for a recessive mutation in CRTA1 (OMIM 610854),
LEPRE1 (OMIM 610915) or PPIB (OMIM 259440) has also
been reported [17,20]. Pyott et al [17] suggested a very low risk
(<0.1%) of recurrence in the absence of parental somatic
mosaicism or recessive inheritance, a risk up to 50% in the
presence of parentalmosaicism, and a risk of 25% if both parents
are carriers of a recessive mutation.
In summary, this report suggests increased NT and hypo-
echogenicity of the cranium are important early ultrasound
adjunctive findings for OI type II.Acknowledgments
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